<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Synthetic Biology News: Promise and Risk</title>
	<atom:link href="http://adambluestein.com/2009/07/synthetic-biology-news-promise-and-risk/feed/" rel="self" type="application/rss+xml" />
	<link>http://adambluestein.com/2009/07/synthetic-biology-news-promise-and-risk/</link>
	<description>Writer &#38; Editor</description>
	<lastBuildDate>Tue, 04 Jan 2011 02:17:02 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: Adam Bluestein &#8250; Another Player on Synthetic Path to Biofuels</title>
		<link>http://adambluestein.com/2009/07/synthetic-biology-news-promise-and-risk/#comment-37</link>
		<dc:creator>Adam Bluestein &#8250; Another Player on Synthetic Path to Biofuels</dc:creator>
		<pubDate>Thu, 30 Jul 2009 16:44:13 +0000</pubDate>
		<guid isPermaLink="false">http://adambluestein.com/?p=593#comment-37</guid>
		<description>[...] to those of Synthetic Genomics&#8217; biofuels joint venture with Exxon, which I recently wrote about. I wonder what this means for LS9, which is also backed by Flagship Ventures and has had a stated [...]</description>
		<content:encoded><![CDATA[<p>[...] to those of Synthetic Genomics&#8217; biofuels joint venture with Exxon, which I recently wrote about. I wonder what this means for LS9, which is also backed by Flagship Ventures and has had a stated [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

